Choy Y S, Dabora S L, Hall F, Ramesh V, Niida Y, Franz D, Kasprzyk-Obara J, Reeve M P, Kwiatkowski D J
Division of Hematology, Brigham and Women Hospital, Boston, Massachussetts 02115, USA.
Ann Hum Genet. 1999 Sep;63(Pt 5):383-91. doi: 10.1046/j.1469-1809.1999.6350383.x.
We evaluated denaturing high pressure liquid chromatography (DHPLC) as a scanning method for mutation detection in TSC2, and compared it to conformation-sensitive gel electrophoresis (CSGE) and single-stranded conformation polymorphism analysis (SSCP). The first 20 exons of TSC2 were amplified from 84 TSC patients and screened initially by CSGE and then by DHPLC. Optimization of DHPLC analysis of each exon was carried out by design of primers with minimum variation in the melting temperature of the amplicon, and titration of both elution gradient and temperature. CSGE analysis identified 40 shifts (21 unique) in the 84 patients and 20 exons. All of these variants were detected by DHPLC, and an additional 27 changes (14 unique) were identified. Overall 15 of 28 (54%) unique single base substitutions were detected by CSGE; all were detected by DHPLC. 25 definite or probable mutations were found in these 84 patients (30%) in exons 1-20 of TSC2. In a subsequent blinded analysis of 15 samples with 18 distinct TSC2 sequence variants originally detected by SSCP in another centre, all variants were detected by DHPLC except one where the variation occurred within the primer. Ten other (7 unique) sequence variants were detected in these samples which had not been detected by SSCP. Overall, 11 of 16 (69%) unique single base substitutions were detected by SSCP; all were detected by DHPLC. We conclude that DHPLC is superior to both CSGE and SSCP for detection of DNA sequence variation in TSC2, particularly for single base substitution mutations.
我们评估了变性高效液相色谱法(DHPLC)作为检测结节性硬化症2型(TSC2)基因突变的扫描方法,并将其与构象敏感性凝胶电泳(CSGE)和单链构象多态性分析(SSCP)进行比较。从84例TSC患者中扩增出TSC2的前20个外显子,首先通过CSGE进行筛查,然后通过DHPLC进行筛查。通过设计扩增子解链温度变化最小的引物,并对洗脱梯度和温度进行滴定,对每个外显子的DHPLC分析进行优化。CSGE分析在84例患者的20个外显子中鉴定出40个条带迁移(21个为独特条带)。所有这些变异均被DHPLC检测到,另外还鉴定出27个变化(14个为独特变化)。总体而言,28个独特的单碱基替换中有15个(54%)被CSGE检测到;所有这些均被DHPLC检测到。在这84例患者中,在TSC2外显子1 - 20中发现了25个确定或可能的突变(30%)。在随后对15个样本的盲法分析中,这些样本最初在另一个中心通过SSCP检测到18个不同的TSC2序列变异,除了一个变异发生在引物内的样本外,所有变异均被DHPLC检测到。在这些样本中还检测到另外10个(7个为独特的)序列变异,而这些变异未被SSCP检测到。总体而言,16个独特的单碱基替换中有11个(约69%)被SSCP检测到;所有这些均被DHPLC检测到。我们得出结论,对于检测TSC2中的DNA序列变异,尤其是单碱基替换突变,DHPLC优于CSGE和SSCP。